Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.7B |
| 2 |
Microsoft
MSFT
|
+$660M |
| 3 |
ExxonMobil
XOM
|
+$621M |
| 4 |
Apple
AAPL
|
+$520M |
| 5 |
UnitedHealth
UNH
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$957M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$477M |
| 3 |
GE Aerospace
GE
|
+$377M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$271M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Financials | 16.95% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Healthcare | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILV
2201
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $11.5M | ﹤0.01% |
1,414,499
+262,568
| +23% | +$2.14M |
|
2202
Lincoln Educational Services
LINC
$1.37B
| $11.5M | ﹤0.01% |
970,425
+50,737
| +6% | +$553K |
|
|
PLYM
2203
DELISTED
Plymouth Industrial REIT
PLYM
| $11.5M | ﹤0.01% |
536,974
+4,265
| +0.8% | +$89.4K |
|
2204
Daily Journal
DJCO
$810M
| $11.5M | ﹤0.01% |
29,040
+5,413
| +23% | +$1.99M |
|
2205
Mesa Laboratories
MLAB
$584M
| $11.4M | ﹤0.01% |
131,891
+8,722
| +7% | +$913K |
|
2206
Cogent Communications
CCOI
$663M
| $11.4M | ﹤0.01% |
201,718
-164,966
| -45% | -$9.85M |
|
2207
Nathan's Famous
NATH
$403M
| $11.4M | ﹤0.01% |
167,947
-2,206
| -1% | -$149K |
|
2208
Vanda Pharmaceuticals
VNDA
$315M
| $11.4M | ﹤0.01% |
2,013,807
+292,172
| +17% | +$1.51M |
|
2209
Utah Medical Products
UTMD
$232M
| $11.4M | ﹤0.01% |
170,310
+8,700
| +5% | +$592K |
|
2210
OmniAb
OABI
$284M
| $11.3M | ﹤0.01% |
3,012,216
+194,835
| +7% | +$888K |
|
2211
NerdWallet
NRDS
$599M
| $11.2M | ﹤0.01% |
769,831
+86,376
| +13% | +$1.18M |
|
|
GNTY
2212
DELISTED
Guaranty Bancshares
GNTY
| $11.2M | ﹤0.01% |
356,012
+12,837
| +4% | +$376K |
|
2213
Hertz
HTZ
$483M
| $11.2M | ﹤0.01% |
3,177,039
-1,378,246
| -30% | -$7.01M |
|
2214
4D Molecular Therapeutics
FDMT
$527M
| $11.2M | ﹤0.01% |
532,742
-216,250
| -29% | -$5.42M |
|
2215
Grupo Cibest SA
CIB
$21.6B
| $11.2M | ﹤0.01% |
341,977
-26,637
| -7% | -$914K |
|
2216
Alico
ALCO
$283M
| $11.1M | ﹤0.01% |
429,309
+8,306
| +2% | +$225K |
|
2217
Arhaus
ARHS
$1.12B
| $11.1M | ﹤0.01% |
655,156
+91,959
| +16% | +$1.49M |
|
2218
Tarsus Pharmaceuticals
TARS
$2.68B
| $11.1M | ﹤0.01% |
406,899
-17,931
| -4% | -$603K |
|
2219
Hingham Institution for Saving
HIFS
$647M
| $11M | ﹤0.01% |
61,503
-2,235
| -4% | -$386K |
|
2220
Advantage Solutions
ADV
$527M
| $11M | ﹤0.01% |
136,289
+55,528
| +69% | +$5.17M |
|
2221
Editas Medicine
EDIT
$407M
| $11M | ﹤0.01% |
2,345,054
-262,711
| -10% | -$1.48M |
|
2222
Civeo
CVEO
$339M
| $11M | ﹤0.01% |
439,427
+39,987
| +10% | +$996K |
|
2223
Limoneira
LMNR
$239M
| $10.9M | ﹤0.01% |
524,788
-13,321
| -2% | -$268K |
|
2224
Ultralife
ULBI
$87.4M
| $10.9M | ﹤0.01% |
1,024,491
+51,399
| +5% | +$547K |
|
2225
Mistras Group
MG
$500M
| $10.9M | ﹤0.01% |
1,311,715
+44,550
| +4% | +$390K |
|
Similar funds
Dimensional Fund Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Dimensional Fund Advisors held 3,454 positions worth $383B, up 3.7% from $369B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Dimensional Fund Advisors deployed $16B of net new capital in Q2 2024, opening 67 new positions and adding to 1,988 existing holdings. Its largest new stake was GE Vernova: 1,030,545 shares worth $177M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $957M trimmed.
- Dimensional Fund Advisors's largest Q2 2024 buy was GE Vernova: 1,030,545 shares worth $177M.
- Dimensional Fund Advisors added most to NVIDIA in Q2 2024, an estimated $1.7B increase.
- Dimensional Fund Advisors's biggest Q2 2024 reduction was Broadcom, cutting an estimated $957M.
- Dimensional Fund Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $477M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $383B portfolio in Q2 2024.
- Dimensional Fund Advisors opened 67 new positions and closed 81 in Q2 2024.
- Dimensional Fund Advisors's portfolio value rose 3.7% quarter-over-quarter to $383B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.